Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329

Watchlist Manager
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Logo
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
Watchlist
Price: 45.46 CNY 0.33% Market Closed
Market Cap: 35B CNY

Profitability Summary

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Margins Comparison
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
35B CNY
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
525.7B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
277B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
220.9B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
271.6B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
148.4B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
35B CNY
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
525.7B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
277B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
220.9B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
271.6B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
148.4B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate